Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2017
At a glance
- Drugs KD 018 (Primary) ; Capecitabine
- Indications Adenocarcinoma; Rectal cancer
- Focus Adverse reactions; Therapeutic Use
- 25 Jul 2017 Planned End Date changed from 1 Jan 2018 to 1 Jul 2018.
- 25 Jul 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jan 2018.
- 06 Jun 2017 Preliminary result presented at the 53rd Annual Meeting of the American Society of Clinical Oncology